{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:13:48Z","timestamp":1785442428688,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11739-016-1450-6","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T11:49:40Z","timestamp":1460720980000},"page":"637-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs"],"prefix":"10.1007","volume":"11","author":[{"given":"Marco","family":"Falcone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"Concia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"1450_CR1","unstructured":"FDA Uncomplicated and Complicated Skin and Skin Structure Infections\u2014Developing Antimicrobial Drugs for Treatment (1998). Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/98fr\/2566dft.pdf .\u00a0Accessed 8 Apr 2016"},{"key":"1450_CR2","unstructured":"FDA Guideline ABSSSI (2013). Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/ucm071185.pdf . Accessed Sept 2015"},{"key":"1450_CR3","unstructured":"Mims C, Playfair J, Roitt I et al. Medical microbiology. Mosby Int Ltd, London. ISBN 0 7234 2781 X"},{"key":"1450_CR4","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjcn.2004.9.Sup1.12495","volume":"9","author":"KF Cutting","year":"2004","unstructured":"Cutting KF, White R (2004) Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 9:S6\u2013S15","journal-title":"Br J Community Nurs"},{"key":"1450_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12245-015-0060-9","volume":"8","author":"M Quirke","year":"2015","unstructured":"Quirke M, Wakai A (2015) Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting. Int J Emerg Med 8:11","journal-title":"Int J Emerg Med"},{"key":"1450_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9610(02)01411-3","volume":"185","author":"SE Wilson","year":"2003","unstructured":"Wilson SE, Solomkin JS, Le V, Cammarata SK, Bruss JB (2003) A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid. Am J Surg 185:369\u2013375","journal-title":"Am J Surg"},{"key":"1450_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijantimicag.2010.03.016","volume":"36","author":"HS Sader","year":"2010","unstructured":"Sader HS, Farrell DJ, Jones RN (2010) Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents 36:28\u201332","journal-title":"Int J Antimicrob Agents"},{"key":"1450_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajic.2010.03.018","volume":"39","author":"KM Itani","year":"2011","unstructured":"Itani KM, Merchant S, Lin SJ et al (2011) Outcomes and management costs in patients hospitalized for skin and skin-structure infections. Am J Infect Control 39:42\u201349","journal-title":"Am J Infect Control"},{"key":"1450_CR9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid1509.081228","volume":"15","author":"J Edelsberg","year":"2009","unstructured":"Edelsberg J, Taneja C, Zervos M (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15:1516\u20131518","journal-title":"Emerg Infect Dis"},{"key":"1450_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","volume":"15","author":"LG Miller","year":"2015","unstructured":"Miller LG, Eisenberg DF, Liu H et al (2015) Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005\u20132010. BMC Infect Dis 15:362","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"1450_CR11","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/cid\/civ528","volume":"61","author":"AF Cardona","year":"2015","unstructured":"Cardona AF, Wilson SE (2015) Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Clin Infect Dis 61(Suppl 2):S69\u2013S78","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"1450_CR12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1089\/sur.2008.066.supp","volume":"9","author":"M Dryden","year":"2008","unstructured":"Dryden M (2008) Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation. Surg Infect (Larchmt) 9(suppl 1):S3\u2013S10","journal-title":"Surg Infect (Larchmt)"},{"key":"1450_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","volume":"89","author":"A Jeng","year":"2010","unstructured":"Jeng A, Beheshti M, Li J, Nathan R (2010) The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore) 89:217\u2013226","journal-title":"Medicine (Baltimore)"},{"key":"1450_CR14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/JCM.05817-11","volume":"50","author":"MJ Zervos","year":"2012","unstructured":"Zervos MJ, Freeman K, Vo L et al (2012) Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microbiol 50:238\u2013245","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"1450_CR15","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/cid\/cir364","volume":"53","author":"TM File","year":"2011","unstructured":"File TM, Solomkin JS, Cosgrove SE (2011) Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clin Infect Dis 53(Suppl 1):S15\u2013S22","journal-title":"Clin Infect Dis"},{"key":"1450_CR16","unstructured":"Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) (2013). Available at http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/antimicrobial-resistance-surveillance-europe-2013.pdf .\u00a0Accessed 8 Apr 2016"},{"key":"1450_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejim.2008.08.016","volume":"20","author":"M Falcone","year":"2009","unstructured":"Falcone M, Serra P, Venditti M (2009) Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians. Eur J Intern Med 20:343\u2013347","journal-title":"Eur J Intern Med"},{"key":"1450_CR18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/eri.11.77","volume":"9","author":"GB Orsi","year":"2011","unstructured":"Orsi GB, Falcone M, Venditti M (2011) Surveillance and management of multidrug-resistant microrganisms. Expert Rev Anti Infect Ther 9:653\u2013679","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1450_CR19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","volume":"355","author":"GJ Moran","year":"2006","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, EMERGEncy ID Net Study Group et al (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666\u2013674","journal-title":"N Engl J Med"},{"key":"1450_CR20","first-page":"865","volume":"78","author":"M Falcone","year":"2012","unstructured":"Falcone M, Venditti M (2012) Community-acquired MRSA: a potentially dangerous but invisible enemy. Miner Anestesiol 78:865\u2013867","journal-title":"Miner Anestesiol"},{"key":"1450_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","volume":"57","author":"GJ Moet","year":"2007","unstructured":"Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR (2007) Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998\u20132004). Diagn Microbiol Infect Dis 57:7\u201313","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1450_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s15010-011-0152-2","volume":"39","author":"M Tinelli","year":"2011","unstructured":"Tinelli M, Mannino S, Lucchi S et al (2011) Healthcare-acquired infections in rehabilitation units of the Lombardy Region, Italy. Infection 39:353\u2013358","journal-title":"Infection"},{"key":"1450_CR23","first-page":"295","volume":"30","author":"R Migliavacca","year":"2007","unstructured":"Migliavacca R, Nucleo E, D\u2019Andrea MM et al (2007) Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities. New Microbiol 30:295\u2013298","journal-title":"New Microbiol"},{"key":"1450_CR24","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF et al (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59:e10\u2013e52","journal-title":"Clin Infect Dis"},{"key":"1450_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11739-012-0796-7","volume":"7","author":"M Falcone","year":"2012","unstructured":"Falcone M, Blasi F, Menichetti F, Pea F, Violi F (2012) Pneumonia in frail older patients: an up to date. Intern Emerg Med 7:415\u2013424","journal-title":"Intern Emerg Med"},{"key":"1450_CR26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1532-5415.2000.tb04783.x","volume":"48","author":"K Rockwood","year":"2000","unstructured":"Rockwood K, Stadnyk K, Carver D et al (2000) A clinimetric evaluation of specialized geriatric care for rural dwelling, frail older people. J Am Geriatr Soc 48:1080\u20131085","journal-title":"J Am Geriatr Soc"},{"key":"1450_CR27","unstructured":"Studio Epidemiologico Longitudinale sull\u2019Invecchiamento (ILSA). http:\/\/www.italz.it\/CNRPFINV\/ilsa.htm .\u00a0Accessed 8 Apr 2016"},{"key":"1450_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2318-13-12","volume":"13","author":"C Marwick","year":"2013","unstructured":"Marwick C, Santiago VH, McCowan C, Broomhall J, Davey P (2013) Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes. BMC Geriatrics 13:12","journal-title":"BMC Geriatrics"},{"key":"1450_CR29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3111\/13696998.2014.940423","volume":"17","author":"H Ostermann","year":"2014","unstructured":"Ostermann H, Blasi F, Medina J et al (2014) Resource use in patients hospitalized with complicated skin and soft skin infections in Europe and analysis of vulnerable groups: the REACH study. J Med Econ 17:719\u2013729","journal-title":"J Med Econ"},{"key":"1450_CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00228-010-0977-0","volume":"67","author":"A Nobili","year":"2011","unstructured":"Nobili A, Licata G, Salerno F et al (2011) Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 67:507\u2013519","journal-title":"Eur J Clin Pharmacol"},{"key":"1450_CR31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2011.08.029","volume":"22","author":"A Nobili","year":"2011","unstructured":"Nobili A, Marengoni A, Tettamanti M et al (2011) Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 22:597\u2013602","journal-title":"Eur J Intern Med"},{"key":"1450_CR32","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by infectious disease society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18\u2013e55","journal-title":"Clin Infect Dis"},{"key":"1450_CR33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.amjmed.2005.04.042","volume":"119","author":"S Harbarth","year":"2006","unstructured":"Harbarth S, Sax H, Fankhauser-Rodriguez C et al (2006) Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 119:275 (e15\u201323)","journal-title":"Am J Med"},{"key":"1450_CR34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/JCM.05817-11","volume":"50","author":"M Zervos","year":"2012","unstructured":"Zervos M, Freeman K, Vo L et al (2012) Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microb 50:238\u2013245","journal-title":"J Clin Microb"},{"key":"1450_CR35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12879-015-0822-2","volume":"15","author":"J Garau","year":"2015","unstructured":"Garau J, Blasi F, Medina J, McBride K, Ostermann H, REACH study group (2015) Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study. BMC Infect Dis 15:78","journal-title":"BMC Infect Dis"},{"key":"1450_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QCO.0000000000000140","volume":"28","author":"S Aliberti","year":"2015","unstructured":"Aliberti S, Giuliani F, Ramirez J, Blasi F (2015) How to choose the duration of antibiotic therapy in patients with pneumonia. Curr Opin Infect Dis 28:177\u2013184","journal-title":"Curr Opin Infect Dis"},{"key":"1450_CR37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.011","volume":"39","author":"M Falcone","year":"2012","unstructured":"Falcone M, Russo A, Pompeo ME et al (2012) Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy. Int J Antimicrob Agents 39:64\u201368","journal-title":"Int J Antimicrob Agents"},{"key":"1450_CR38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijantimicag.2014.04.007","volume":"44","author":"C Eckmann","year":"2014","unstructured":"Eckmann C, Lawson W, Nathwani D et al (2014) Antibiotic treatment pattern across Europe in patients with complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 44:56\u201364","journal-title":"Int J Antimicrob Agents"},{"key":"1450_CR39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18553\/jmcp.2003.9.4.317","volume":"9","author":"S Parodi","year":"2003","unstructured":"Parodi S, Rhew DC, Goetz MB (2003) Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections. J Manag Care Pharm 9:317\u2013326","journal-title":"J Manag Care Pharm"},{"key":"1450_CR40","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Infectious Diseases Society of America et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18\u2013e55","journal-title":"Clin Infect Dis"},{"key":"1450_CR41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","volume":"115","author":"DP Levine","year":"1991","unstructured":"Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674\u2013680","journal-title":"Ann Intern Med"},{"key":"1450_CR42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, Peacock JE Jr, Musher DM et al (2003) Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333\u2013339","journal-title":"Medicine (Baltimore)"},{"key":"1450_CR43","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.01708-10","volume":"55","author":"JA Roberts","year":"2011","unstructured":"Roberts JA, Taccone FS, Udy AA et al (2011) Vancomycin dosing in critically ill patients. Antimicrob Agents Chemother 55:2704\u20132709","journal-title":"Antimicrob Agents Chemother"},{"key":"1450_CR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","volume":"52","author":"N Patel","year":"2011","unstructured":"Patel N, Pai MP, Rodvold KA et al (2011) Vancomycin: we can\u2019t get there from here. Clin Infect Dis 52:969\u2013974","journal-title":"Clin Infect Dis"},{"key":"1450_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06330.x","volume":"1241","author":"KJ Shaw","year":"2011","unstructured":"Shaw KJ, Barbachyn MR (2011) The oxazolidinones: past, present, and future. Ann N Y Acad Sci 1241:48\u201370","journal-title":"Ann N Y Acad Sci"},{"key":"1450_CR46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FB, Campanaro E, Eisenstein BI, Daptomycin 98-01 and 99-01 Investigators (2004) The safety and efficacy of daptomycin for the treatment of complicated skin and skin structure infections. Clin Infect Dis 38:1673\u20131681","journal-title":"Clin Infect Dis"},{"key":"1450_CR47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1592\/phco.27.12.1611","volume":"27","author":"SL Davis","year":"2007","unstructured":"Davis SL, McKinnon PS, Hall LM et al (2007) Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes. Pharmacotherapy 27:1611\u20131618","journal-title":"Pharmacotherapy"},{"key":"1450_CR48","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cit582","volume":"57","author":"M Falcone","year":"2013","unstructured":"Falcone M, Russo A, Venditti M, Novelli A, Pai MP (2013) Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 57:1568\u20131576","journal-title":"Clin Infect Dis"},{"key":"1450_CR49","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","volume":"49","author":"J Breedt","year":"2005","unstructured":"Breedt J, Teras J, Gardovskis J et al (2005) Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother 49:4658\u20134666","journal-title":"Antimicrob Agents Chemother"},{"key":"1450_CR50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/655827","volume":"51","author":"GR Corey","year":"2010","unstructured":"Corey GR, Wilcox M, Talbot GH et al (2010) Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 51:641\u2013650","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1450_CR51","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/cid\/cit618","volume":"58","author":"D Das","year":"2014","unstructured":"Das D, Tulkens PM, Mehra P, Fang E, Prokocimer P (2014) Tedizolid\u00a0phosphate\u00a0for the\u00a0management\u00a0of\u00a0acute\u00a0bacterial\u00a0skin\u00a0and\u00a0skin\u00a0structure\u00a0infections:\u00a0safety\u00a0summary. Clin Infect Dis 58(Suppl 1):S51\u2013S57","journal-title":"Clin Infect Dis"},{"key":"1450_CR52","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/497271","volume":"41","author":"LE Jauregui","year":"2005","unstructured":"Jauregui LE, Babazadeh S, Seltzer E et al (2005) Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 41:1407\u20131415","journal-title":"Clin Infect Dis"},{"key":"1450_CR53","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","volume":"370","author":"HW Boucher","year":"2014","unstructured":"Boucher HW, Wilcox M, Talbot GH et al (2014) Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 370:2169\u20132179","journal-title":"N Engl J Med"},{"key":"1450_CR54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/526772","volume":"46","author":"M Billeter","year":"2008","unstructured":"Billeter M, Zervos MJ, Chen AY, Dalovisio JR, Kurukularatne C (2008) Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic. Clin Infect Dis 46:577\u2013583","journal-title":"Clin Infect Dis"},{"key":"1450_CR55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","volume":"62","author":"MW Dunne","year":"2015","unstructured":"Dunne MW, Puttagunta S, Giordano P et al (2015) A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis 62:545\u2013551","journal-title":"Clin Infect Dis"},{"key":"1450_CR56","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1310422","volume":"370","author":"GR Corey","year":"2014","unstructured":"Corey GR, Kabler H, Mehra P et al (2014) Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med 370:2180\u20132190","journal-title":"N Engl J Med"},{"key":"1450_CR57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciu778","volume":"60","author":"GR Corey","year":"2015","unstructured":"Corey GR, Good S, Jiang H et al (2015) Single-dose oritavancin versus 7\u201310\u00a0days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study. Clin Infect Dis 60:254\u2013262","journal-title":"Clin Infect Dis"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1450-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-016-1450-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1450-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T22:44:53Z","timestamp":1655505893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-016-1450-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s11739-016-1450-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}